HALEY RUBIO: Open Payments
NPI 1598394371 · SAN MARCOS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 21 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $64 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $147 |
| Xeris Pharmaceuticals, Inc. | 4 | $76 |
| Lilly USA, LLC | 3 | $49 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Edwards Lifesciences Corporation | 1 | $43 |
| SCILEX PHARMACEUTICALS INC. | 2 | $40 |
| ABBVIE INC. | 1 | $29 |
| Novo Nordisk Inc | 1 | $22 |
| Hologic Sales and Service, LLC | 1 | $17 |
| ViiV Healthcare Company | 1 | $15 |
Products named: REZDIFFRA, GVOKE HYPOPEN, SHINGRIX, SAPIEN 3 Ultra RESILIA, ELYXYB - CELECOXIB, MOUNJARO, UBRELVY, Wegovy.
Industry payments across CA — which companies pay providers there.
